secwatch.observer — SEC 8-K summary
======================================

Issuer:     HARVARD BIOSCIENCE INC (HBIO)
CIK:        0001123494
Form:       8-K
Filed at:   2022-01-28T23:59:59+00:00
Accession:  0001193805-22-000124
Event type: leadership
Sentiment:  negative
Materiality: 0.60
Item codes: 1.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Harvard Bioscience COO Ken Olson resigns, enters separation agreement
---------------------------------------------------------------------

- Ken Olson resigned as COO effective January 31, 2022 for personal reasons.
- Separation agreement signed Jan 26, 2022 provides salary through Dec 31, 2022.
- Olson will provide remote assistance on projects and transition of duties until Dec 31, 2022.
- Resignation was not due to any disagreement with company operations, policies, or practices.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1123494/000119380522000124/0001193805-22-000124-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1123494/000119380522000124/e621242_8k-hbi.htm
  HTML page:      https://secwatch.observer/filing/0001193805-22-000124

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer